Bendamustine Hydrochloride: Medgend

Bendamustine Hydrochloride FDA Approved Drugs

BENDAMUSTINE HYDROCHLORIDE [Bendamustine Hydrochloride^{C₁₆H₂₁Cl₂N₃O₂ClH}]

100mg/vial (iv (infusion) powder)

25mg/vial (iv (infusion) powder)

Accord Hlthcare^{May 19, 2016}
Breckenridge Pharm^{Dec 29, 2016}
Glenmark Pharms Ltd^{Mar 24, 2016}
Hospira Inc^{May 20, 2016}
Innopharma Licensing^{Mar 24, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BENDEKA [Bendamustine Hydrochloride^{C₁₆H₂₁Cl₂N₃O₂ClH}]

100mg/4ml (25mg/ml) (iv (infusion) solution)

Eagle Pharms^{Dec 7, 2015}

For the treatment of patients with chronic lymphocytic leukemia.
For the treatment of patients with indolent b-cell non-hodgkin lymphoma.
For use in the treatment of patients with chronic lymphocytic leukemia and/or non-hodgkins lymphoma.
For use in treatment of patients with chronic lymphocytic leukemia (cll) and/or non-hodgkin's lymphoma.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TREANDA [Bendamustine Hydrochloride^{C₁₆H₂₁Cl₂N₃O₂ClH}]

100mg/vial (iv (infusion) powder)

180mg/2ml (90mg/ml) (iv (infusion) solution)

25mg/vial (iv (infusion) powder)

45mg/0.5ml (90mg/ml) (iv (infusion) solution)

Cephalon^{Mar 20, 2008}

For use in the treatment of patients with chronic lymphocytic leukemia (cll) and/or indolent b-cell non-hodgkin lymphoma (nhl).
For use in the treatment of patients with chronic lymphocytic leukemia (cll).
For use in the treatment of patients with chronic lymphocytic leukemia and/or non-hodgkins lymphoma.
For use in the treatment of patients with indolent b-cell non-hodgkin lymphoma.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Bendamustine Hydrochloride FDA Approved Drugs